Loading...
Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer
We report unexpectedly high efficacy of temsirolimus as third-line treatment in a patient with metastatic chromophobe renal cell carcinoma. After failure of two sequentially administered tyrosine kinase inhibitors, treatment with temsirolimus resulted in a prolonged partial remission of 14 months, a...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
S. Karger AG
2011
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3082484/ https://ncbi.nlm.nih.gov/pubmed/21526001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000323804 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|